James J. Saller

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

Ben Creelan, Chao Wang, Jamie K. Teer et al. · Nature Medicine · 2021 · 400 citations · Full text

Tumor-infiltrating Lymphocyte Treatment, Cancer Immunosurveillance, Medicine +10

Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

Jhanelle E. Gray, Andreas Saltos, Tawee Tanvetyanon et al. · Clinical Cancer Research · 2019 · 136 citations · Full text

Proteogenomic landscape of squamous cell lung cancer

Paul A. Stewart, Eric A. Welsh, Robbert J.C. Slebos et al. · Nature Communications · 2019 · 117 citations · Full text

Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer

Bradford A. Perez, Sungjune Kim, Min-Hsuan Wang et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 45 citations · Full text

Oncology, Thoracic Radiation Therapy, Immune Checkpoint Inhibitor +5

Hypoxia-Related Radiomics and Immunotherapy Response: A Multicohort Study of Non-Small Cell Lung Cancer

Ilke Tunali, Yan Tan, Jhanelle E. Gray et al. · JNCI Cancer Spectrum · 2021 · 40 citations · Full text